Breast cancer (BC) research has suffered from a lack of model systems that can recapitulate the complex 3D microenvironment that exists within the tumor. This has limited the translation of many promising pre-clinical therapies into clinical application. The tumor microenvironment significantly influences BC cell phenotype and similarly the microenvironment is modulated by the tumor cells themselves. In the breast, adipose stromal cells (ASCs) and mature adipocytes are thought to affect BC cells via paracrine signaling as well as through direct metabolic effects; immune cells and fibroblasts may promote desmoplasia; stiffer extracellular matrices are thought to enhance cancer aggression. Herein, we present an organotypic model of BC, with the full complement of breast adipose, vascular, and epithelial cells, functional epithelial ducts, and vascular channels within a biocompatible and tunable collagen construct. We tune the mechanical and cellular properties of this system to study their influence on tumor progression and vascular remodeling.
METHODS:
Discarded tissue was acquired from patients undergoing breast reductions and abdominoplasties and digested to retrieve adipocytes and stromal cells. Adipocytes and stromal cells were encapsulated into type I collagen and injected into a polydimethylsiloxane base which was fabricated using positive molds constructed by additive manufacturing (3D printing). Three 1mm diameter lumens were formed and seeded with fluorescently labeled vascular cells, MDAMB 231 (BC cell line), and epithelial cells, to mimic the vasculature, ductal carcinoma, and healthy breast ducts, respectively. The adipocytes were also fluorescently labeled with the lipid dye boron-dipyrromethene (BODIPY 493/503 and BC cell invasion into the collagen-stromal bulk was analyzed with confocal microscopy.
RESULTS:
Over 40 adipose tissue specimens were collected and included in a tissue biobank. The collagen hydrogel bulk demonstrated a dense culture of mature adipocytes containing fluorescent lipid droplets neighbored by stromal cells, mimicking the native architecture of breast adipose tissue. The fluorescent tags allowed for observation of each of the 3 luminal structures. Metastatic potential was evaluated by assessing BC cell invasion from the lumen into stromal cell-containing hydrogels. Within the ductal carcinoma lumen, BC cells formed a mass of cells and fluorescently tagged cells were observed leaving the original lumen into the breast stromal bulk collagen. In the vascular lumen, green fluorescent endothelial cells formed a single layer along the lumen. Vascular remodeling was analyzed by endothelial cell lining disruption.
CONCLUSION:
We have established a novel 3D biomimetic tissue engineered platform to study the BC microenvironment, utilizing primary cells derived from specific patients' tissues. Our high fidelity biomimetic platform provides the means for more accurate interrogation of the complex interplay within the BC tumor microenvironment and will allow for high-throughput diagnostic and therapeutic analyses in a patient-specific manner. 
PURPOSE:
Traumatic soft tissue injuries to the face and extremities with associated volumetric muscle loss can result in devastating functional deficits, and there are currently no available treatments to stimulate the repair or regeneration of functional skeletal muscle in patients with these debilitating injuries. Decellularized extracellular matrix has been a promising candidate for induction of skeletal myocyte regeneration. However, functionalization of the regenerated tissue requires motor nerve innervation and the presence of motor end plates to properly contract. Nerve-specific growth factors have also been demonstrated to enhance muscle regeneration. In this study, we examined the myogenic and neurogenic effects through direct neurotization of decellularized muscle extracellular matrix.
METHODS:
External oblique muscles were harvested from adult Sprague-Dawley rats and underwent a negative pressure assisted decellularization process to generate decellularized muscle matrix. Bilateral full-thickness, 1 cm latissimus dorsi defects were surgically created in 12 rats. 8 defects were left as is, 8 defects were implanted with decellularized matrix alone, and 8 defects were implanted with decellularized matrix then neurotized. Peripheral motor PRS Global Open • 2018 nerves innervating the panniculus carnosus were microsugically dissected free and transected distally to allow transposition onto the ipsilateral decellularized matrix implant. Neurotization was performed on both the deep and superficial surfaces of the matrix with 3-5 nerves total implanted based on anatomic feasibility. Rats were sacrificed and tissue harvest was carried out on post-operative days 90 and 180. Tissue samples were assessed through gross appearance, immunohistochemistry, and western blot analysis for myogenesis, inflammation, neovascularity, and neural ingrowth within the explanted matrices and defects alone.
RESULTS:
At the time of tissue harvest, both the neurotized and non-neurotized matrices appeared well integrated within the surrounding native muscle as compared to the defect alone, which healed with a thin layer of fibrous connective tissue. However, neurotized decellularized muscle matrix demonstrated greater infiltration by mature myocytes compared to non-neurotized control implants based on myosin heavy chain analysis. CD-31 staining revealed similar levels of microvascular networks within the matrix of neurotized and non-neurotized matrices, both greater than defect alone. Cholinergic neural tissue ingrowth was only observed in neurotized muscle matrix. Direct stimulation of the matrix implants with a peripheral nerve stimulator demonstrated contraction of both the neurotized and non-neurotized matrices, however a difference could not be grossly appreciated.
CONCLUSION:
Direct neurotization of decellularized muscle matrix in a model of volumetric muscle loss leads to more robust myogenesis and neurogenesis within the implant as compared to non-neurotized matrix and defect alone. Further studies are needed to evaluate functional differences in more detail. 
PURPOSE:
With an aging population, degenerative diseases such as osteoarthritis are expected to increase. Hyaline cartilage has a poor propensity to regenerate. To ameliorate its healing capacity patients are being offered multiple "stem cell" therapies with little or no evidence behind their claims. With a unique insight into the Skeletal Stem Cell we aim to share new insights into our manipulation of the SSC through surgical, biochemical and cellular treatments.
METHODS:
Skeletally mature mice were used throughout. An N=10 was used for each group unless stated. Clonality was assessed using Actin and Sox9 Cre-ER Rainbow mouse models induced with tamoxifen. Cell number was assessed with FACS using previously published FACS gating profiles. Proliferation was assessed using EdU assays by IHC and intracellular FACS. Cellular origin was assessed with our parabiosis model. Differentiation capacity was assessed in vitro and in vivo (both subcapsular and orthotopic). Biochemical manipulation used hydrogel and collagen scaffolds. Cellular treatments used labelled cell population transplantation orthotopically.
RESULTS:
Following surgical manipulation, clonality was confirmed within the regenerate. A significant increase (p<0.05) in the number of SSC was seen at 1 and 2 weeks post operatively. The regenerate contained proliferating cells. There was a significant increase (p<0.05) in SSC proliferation following surgery. The significant increase in SSC within the area was due to a local increase of SSC. The fate of those SSC is affected by our temporal biochemical factors following injury. Addition of prospective FACS isolated cellular subpopulations augments the native SSC population.
CONCLUSIONS:
Our approach to manipulating SSC fate towards hyaline cartilage regeneration is a novel, cell-specific, targeted therapy. We now aim to translate this research into the clinical setting and optimize our protocol for regenerating hyaline cartilage. 
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